Tuesday, November 5

BioNTech-Pfizer have said their vaccine showed 100 per cent efficacy against the coronavirus in 12- to 15-year-olds, as they eye approval for adolescents to get the jabs before the next school year.

Pfizer-BioNTech says Covid-19 vaccine is safe, effective on adolescents

TRT World says BioNTech-Pfizer have said their vaccine showed 100 per cent efficacy against the coronavirus in 12- to 15-year-olds, as they eye approval for adolescents to get the jabs before the next school year.

Phase 3 trials carried out on 2,260 adolescents in the United States “demonstrated 100 per cent efficacy and robust antibody responses,” the companies said in a statement on Wednesday.

https://wtxnews.com/uk/met-police-allegations-covid-19-variants/

New Zealand provisionally approved the use of the Pfizer-BioNTech COVID-19 vaccine, with the first delivery expected by end-March https://t.co/Gh0xyt6oYQ pic.twitter.com/U0kUTn99uW
— Reuters (@Reuters) February 3, 2021